Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITY

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study includes a screening period (up to 8 weeks), a primary analysis period (up to 28 weeks), a long-term extension period for selected participants (28 weeks) and a 24-week follow-up period only for eligible participants.

Detailed Description

Simple Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.

Call 1800-9860-568 now to find out if you are eligible.

Age icon
Age
18 - None
Gender icon
Gender
All
NCT ID icon
NCT ID
NCT07007962
Phase icon
Phase
3
Status icon
Status
Recruiting Now
Medical Condition icon
Medical Condition
IDIOPATHIC THROMBOCYTOPENIC PURPURA

How is Plaque Psoriasis treated?

Medical Condition icon
Medical Condition
A short sentence to introduce what to expect in the about condition section
Learn more
Study icon
The Study
A short sentence to introduce what to expect in the about condition section
Learn more
Clinical Trials icon
About Clinical Trials
A short sentence to introduce what to expect in the about condition section
Learn more

Your Journey

01
Receiving the medication
You would receive etanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept, as well as study related medical care, is provided at no cost.
02
Visiting the study site
Study participation involves approximately 8 visits to your local study center over 6 to 7 months.
03
Follow-up
There would also be a follow-up telephone call 30days after completing the study. No visits are required after participation is complete.

Call 1800-9860-568 now to find out if you are eligible.